188 related articles for article (PubMed ID: 34301626)
1. Three-dimensional missense tolerance ratio analysis.
Perszyk RE; Kristensen AS; Lyuboslavsky P; Traynelis SF
Genome Res; 2021 Aug; 31(8):1447-1461. PubMed ID: 34301626
[TBL] [Abstract][Full Text] [Related]
2. Compendium of proteins containing segments that exhibit zero-tolerance to amino acid variation in humans.
Sanders AL; Hermanson JN; Samuels DC; Plate L; Sanders CR
Protein Sci; 2022 Sep; 31(9):e4408. PubMed ID: 36040257
[TBL] [Abstract][Full Text] [Related]
3. CRIMEtoYHU: a new web tool to develop yeast-based functional assays for characterizing cancer-associated missense variants.
Mercatanti A; Lodovichi S; Cervelli T; Galli A
FEMS Yeast Res; 2017 Dec; 17(8):. PubMed ID: 29069390
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic missense protein variants affect different functional pathways and proteomic features than healthy population variants.
Laddach A; Ng JCF; Fraternali F
PLoS Biol; 2021 Apr; 19(4):e3001207. PubMed ID: 33909605
[TBL] [Abstract][Full Text] [Related]
5. Genetic intolerance analysis as a tool for protein science.
Li GC; Forster-Benson ETC; Sanders CR
Biochim Biophys Acta Biomembr; 2020 Jan; 1862(1):183058. PubMed ID: 31494120
[TBL] [Abstract][Full Text] [Related]
6. Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation.
Traynelis J; Silk M; Wang Q; Berkovic SF; Liu L; Ascher DB; Balding DJ; Petrovski S
Genome Res; 2017 Oct; 27(10):1715-1729. PubMed ID: 28864458
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variants.
Iqbal S; Pérez-Palma E; Jespersen JB; May P; Hoksza D; Heyne HO; Ahmed SS; Rifat ZT; Rahman MS; Lage K; Palotie A; Cottrell JR; Wagner FF; Daly MJ; Campbell AJ; Lal D
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28201-28211. PubMed ID: 33106425
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide identification, characterization and classification of ionotropic glutamate receptor genes (iGluRs) in the malaria vector Anopheles sinensis (Diptera: Culicidae).
Wang TT; Si FL; He ZB; Chen B
Parasit Vectors; 2018 Jan; 11(1):34. PubMed ID: 29334982
[TBL] [Abstract][Full Text] [Related]
9. MTR-Viewer: identifying regions within genes under purifying selection.
Silk M; Petrovski S; Ascher DB
Nucleic Acids Res; 2019 Jul; 47(W1):W121-W126. PubMed ID: 31170280
[TBL] [Abstract][Full Text] [Related]
10. Understanding the impacts of missense mutations on structures and functions of human cancer-related genes: A preliminary computational analysis of the COSMIC Cancer Gene Census.
Malhotra S; Alsulami AF; Heiyun Y; Ochoa BM; Jubb H; Forbes S; Blundell TL
PLoS One; 2019; 14(7):e0219935. PubMed ID: 31323058
[TBL] [Abstract][Full Text] [Related]
11. Predicting functional consequences of mutations using molecular interaction network features.
Ozturk K; Carter H
Hum Genet; 2022 Jun; 141(6):1195-1210. PubMed ID: 34432150
[TBL] [Abstract][Full Text] [Related]
12. KVarPredDB: a database for predicting pathogenicity of missense sequence variants of keratin genes associated with genodermatoses.
Ying Y; Lu L; Banerjee S; Xu L; Zhao Q; Wu H; Li R; Xu X; Yu H; Neculai D; Xi Y; Yang F; Qin J; Li C
Hum Genomics; 2020 Dec; 14(1):45. PubMed ID: 33287903
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. PremPS: Predicting the impact of missense mutations on protein stability.
Chen Y; Lu H; Zhang N; Zhu Z; Wang S; Li M
PLoS Comput Biol; 2020 Dec; 16(12):e1008543. PubMed ID: 33378330
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction Interfaces.
Engin HB; Kreisberg JF; Carter H
PLoS One; 2016; 11(4):e0152929. PubMed ID: 27043210
[TBL] [Abstract][Full Text] [Related]
16. Analysis and Interpretation of the Impact of Missense Variants in Cancer.
Petrosino M; Novak L; Pasquo A; Chiaraluce R; Turina P; Capriotti E; Consalvi V
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063805
[TBL] [Abstract][Full Text] [Related]
17. News from the protein mutability landscape.
Hecht M; Bromberg Y; Rost B
J Mol Biol; 2013 Nov; 425(21):3937-48. PubMed ID: 23896297
[TBL] [Abstract][Full Text] [Related]
18. GeVIR is a continuous gene-level metric that uses variant distribution patterns to prioritize disease candidate genes.
Abramovs N; Brass A; Tassabehji M
Nat Genet; 2020 Jan; 52(1):35-39. PubMed ID: 31873297
[TBL] [Abstract][Full Text] [Related]
19. UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity -- application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2.
Frédéric MY; Lalande M; Boileau C; Hamroun D; Claustres M; Béroud C; Collod-Béroud G
Hum Mutat; 2009 Jun; 30(6):952-9. PubMed ID: 19370756
[TBL] [Abstract][Full Text] [Related]
20. MTR3D: identifying regions within protein tertiary structures under purifying selection.
Silk M; Pires DEV; Rodrigues CHM; D'Souza EN; Olshansky M; Thorne N; Ascher DB
Nucleic Acids Res; 2021 Jul; 49(W1):W438-W445. PubMed ID: 34050760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
